-transparent.png){kind=logo}
6-Chloropurine arabinoside (3a) was obtained by treatment of the 2'-O-acetylated congener (2) with ammonia in methanol. The 3',5'-di-O-tritylated riboside (6) was allowed to react with diethylaminosulfur trifluoride (DAST) in the presence of pyridine to give the 2'-deoxy-2'-fluoroarabinoside (7), from which 6-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)purine (3b) was obtained. The antiviral effects of 3a and 3b were assayed against several DNA and RNA viruses. Only 3a displayed potent activity against varicella-zoster virus (VZV). This antiviral activity was dependent on phosphorylation by the VZV-induced thymidine kinase (TK). Compound 3a showed moderate activity against other DNA viruses, herpes simplex type 1 (HSV-1) and type 2 (HSV-2), and vaccinia virus. They were equally active against TK- and TK+ strains of HSV-1, which suggests that the HSV-1-encoded TK does not play a role in the anti-HSV-1 activity. No activity was noted with any of the compounds against various RNA viruses, including human immunodeficiency virus, at subtoxic concentrations.
T Maruyama, and
Y Sato, and
Y Oto, and
Y Takahashi, and
R Snoeck, and
G Andrei, and
M Witvrouw, and
E De Clercq
January 1999,
Nucleosides & nucleotides,
T Maruyama, and
Y Sato, and
Y Oto, and
Y Takahashi, and
R Snoeck, and
G Andrei, and
M Witvrouw, and
E De Clercq
April 2022,
Chemical biology & drug design,
T Maruyama, and
Y Sato, and
Y Oto, and
Y Takahashi, and
R Snoeck, and
G Andrei, and
M Witvrouw, and
E De Clercq
January 1990,
Journal of medicinal chemistry,
T Maruyama, and
Y Sato, and
Y Oto, and
Y Takahashi, and
R Snoeck, and
G Andrei, and
M Witvrouw, and
E De Clercq
March 1991,
Journal of medicinal chemistry,
T Maruyama, and
Y Sato, and
Y Oto, and
Y Takahashi, and
R Snoeck, and
G Andrei, and
M Witvrouw, and
E De Clercq
April 2022,
Bioorganic & medicinal chemistry letters,
T Maruyama, and
Y Sato, and
Y Oto, and
Y Takahashi, and
R Snoeck, and
G Andrei, and
M Witvrouw, and
E De Clercq
April 2009,
Bioorganic & medicinal chemistry,
T Maruyama, and
Y Sato, and
Y Oto, and
Y Takahashi, and
R Snoeck, and
G Andrei, and
M Witvrouw, and
E De Clercq
December 2011,
Bioorganic & medicinal chemistry letters,
T Maruyama, and
Y Sato, and
Y Oto, and
Y Takahashi, and
R Snoeck, and
G Andrei, and
M Witvrouw, and
E De Clercq
August 2005,
Journal of medicinal chemistry,
T Maruyama, and
Y Sato, and
Y Oto, and
Y Takahashi, and
R Snoeck, and
G Andrei, and
M Witvrouw, and
E De Clercq
January 2020,
Nucleosides, nucleotides & nucleic acids,
T Maruyama, and
Y Sato, and
Y Oto, and
Y Takahashi, and
R Snoeck, and
G Andrei, and
M Witvrouw, and
E De Clercq
March 2020,
Molecules (Basel, Switzerland),
